11 followers
miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway. - PubMed - NCBI https://t.co/K5whQZM5Fs
miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway. - PubMed - NCBI https://t.co/K5whQZM5Fs
miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway. https://t.co/8K37zRWhOn